The current price is in 116,30$, In this post we are going to talk about the listed company Horizon Pharma PLC, its leaders are Jeffrey D. Kent (Executive VP-Medical Affairs & Outcomes Research), Jeffrey W. Sherman (Chief Medical Officer & Executive Vice President), Karin Rosen (Chief Scientific Officer), Paul W. Hoelscher (Chief Financial Officer & Executive Vice President), Timothy P. Walbert (Chairman, President & Chief Executive Officer), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the Europe region.
Today this action begins with yesterday's closing price, desconocido$.
With an intraday difference of 116,32$ moving between 116,26$ and 116,38$, it is a notable difference that allows quick purchases and sales.
He earns an annual income of desconocido.
The last registered opening is of desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
